推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 記者胡建輝由中國(guó)農(nóng)工民主黨中央、國(guó)家中醫(yī)藥管理局主辦的首屆中醫(yī)科學(xué)大會(huì)在北京召開。會(huì)議以“中醫(yī)藥——國(guó)家戰(zhàn)略資源”為主題，以“科學(xué)認(rèn)識(shí)中醫(yī)藥，促進(jìn)中醫(yī)藥傳承和創(chuàng)新”為宗旨，提出統(tǒng)籌謀劃，深化改革，加快推動(dòng)中醫(yī)藥事業(yè)發(fā)展的戰(zhàn)略目標(biāo)。
國(guó)家衛(wèi)生計(jì)生委副主任、國(guó)家中醫(yī)藥管理局局長(zhǎng)王國(guó)強(qiáng)在會(huì)上指出，近期將做好10個(gè)方面的重點(diǎn)工作，包括加強(qiáng)中醫(yī)藥發(fā)展戰(zhàn)略研究，進(jìn)一步做好頂層設(shè)計(jì)；深度參與醫(yī)改，進(jìn)一步發(fā)揮獨(dú)特作用；加快中醫(yī)藥法立法進(jìn)程，進(jìn)一步加強(qiáng)中醫(yī)藥法制建設(shè)等。
他說，要推進(jìn)公立中醫(yī)醫(yī)院改革中探索建立發(fā)揮中醫(yī)藥特色優(yōu)勢(shì)的政策機(jī)制，完善中醫(yī)藥服務(wù)提供和利用的鼓勵(lì)政策，推進(jìn)縣鄉(xiāng)中醫(yī)藥服務(wù)一體化管理，推動(dòng)社會(huì)辦中醫(yī)，改進(jìn)中醫(yī)類別醫(yī)師執(zhí)業(yè)管理，探索基本公共衛(wèi)生服務(wù)中醫(yī)藥新項(xiàng)目。
關(guān)于加快中醫(yī)藥法立法進(jìn)程，王國(guó)強(qiáng)說，要深入落實(shí)黨的十八屆四中全會(huì)精神，以推進(jìn)中醫(yī)藥法立法為統(tǒng)領(lǐng)，研究提出中醫(yī)藥法制體系框架，加強(qiáng)中醫(yī)藥法提出的相關(guān)制度安排的配套文件研究，做好中醫(yī)藥法實(shí)施準(zhǔn)備工作，加快推進(jìn)國(guó)家中醫(yī)藥管理局規(guī)范性文件的制修訂，加強(qiáng)合法性審查。
